Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Identifying Indicators for Major Depressive Disorder in a Naturalistic Clinical Program, the Major Depressive Disorder Integrated Care Pathway (MDD-ICP)

EF 2023-24

Résumé
Quality of life is lower in patients experiencing Major Depressive Disorder (MDD). Individuals suffering often experience co-morbid physical and psychiatric illnesses as well as incur a reduced life expectancy. MDD patient care is often a long reiterative process that requires multiple trials and evaluations of response, thus demonstrating the need to identify indicators to efficiently tailor treatment. The aim of this research is to recognize indicators within MDD through the collection of patient data from the Integrative Care Pathway (ICP). The MDD-ICP is an evidence-based clinical practice that utilizes measurement and structured based care. Thus, the program allows for the optimal infrastructure to collect clinical data and measure biological markers. Biomarkers are determined by analysis of wearable technology measures; sleep patterns and activity, and by future genetic analysis of the collected saliva samples. By analyzing the aforementioned clinical and biological data in 100 patients over 2 years, MDD can be better understood in a way that is reflective of a more diverse population and can be applied to improve patient care. This study will be executed at the Centre for Addictions and Mental Health through recruitment of patients currently or soon to be enrolled in the MDD-ICP. This accredited practice will allow the collection of longitudinal patient data from the MDD-ICP itself, in extension the study will acquire self-reports, activity and sleep cycle patterns from actigraph software, and saliva sample derived genomic data. Collection and analysis of clinical and biological data ensures we are able to recognize and understand underlying indicators of MDD so that we can utilize this knowledge to optimally tailor patient care within a shorter time frame.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506343
Name
Verma Siya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying Indicators for Major Depressive Disorder in a Naturalistic Clinical Program, the Major Depressive Disorder Integrated Care Pathway (MDD-ICP)
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker Identification; Individualized Treatment; Integrated Care Pathway; Learning Health Systems; Longitudinal Clinical Data Capture; Major Depressive Disorder; Measurement-Based Structured Treatment; Multidisciplinary; Precision Medicine; Psychiatry
Abstract
Quality of life is lower in patients experiencing Major Depressive Disorder (MDD). Individuals suffering often experience co-morbid physical and psychiatric illnesses as well as incur a reduced life expectancy. MDD patient care is often a long reiterative process that requires multiple trials and evaluations of response, thus demonstrating the need to identify indicators to efficiently tailor treatment. The aim of this research is to recognize indicators within MDD through the collection of patient data from the Integrative Care Pathway (ICP). The MDD-ICP is an evidence-based clinical practice that utilizes measurement and structured based care. Thus, the program allows for the optimal infrastructure to collect clinical data and measure biological markers. Biomarkers are determined by analysis of wearable technology measures; sleep patterns and activity, and by future genetic analysis of the collected saliva samples. By analyzing the aforementioned clinical and biological data in 100 patients over 2 years, MDD can be better understood in a way that is reflective of a more diverse population and can be applied to improve patient care. This study will be executed at the Centre for Addictions and Mental Health through recruitment of patients currently or soon to be enrolled in the MDD-ICP. This accredited practice will allow the collection of longitudinal patient data from the MDD-ICP itself, in extension the study will acquire self-reports, activity and sleep cycle patterns from actigraph software, and saliva sample derived genomic data. Collection and analysis of clinical and biological data ensures we are able to recognize and understand underlying indicators of MDD so that we can utilize this knowledge to optimally tailor patient care within a shorter time frame.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Verma, Siya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~